Joseph Bowler focuses his practice on patent prosecution and counseling for clients in the life sciences and biotechnology industries. He has extensive knowledge in the areas of protein biochemistry, synthetic biology, and next-generation sequencing.

Joseph's doctoral work at Florida State University focused on investigating the mechanism of small-molecule activation of an enzyme implicated in the pathogenesis of diabetes. He also developed an in vivo screening method which integrated a plasmid-based library with a genetic selection system to identify novel therapeutic peptides.

  • Boston Patent Law Association
  • Joseph M. Schor Fellowship in Biochemistry, Florida State University
  • Trustee Academic Scholarship, Suffolk University Law School
  • Jurisprudence Award in Professional Responsibility, Suffolk University Law School

Blogs

May 1, 2017

In IPRs, Section 112 Can Play a Critical Role—Even Late in the Game



Scientific Publications

Whittington AC, Larion M, Bowler JM, Ramsey KM, Brüschweiler R, Miller BG. (2015) Dual allosteric activation mechanisms in monomeric human glucokinase. Proc Natl Acad Sci USA. 15;112(37):11553-8. 

Bowler JM, Hervert KL, Kearley ML, Miller BG. (2013) Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose. ACS Med Chem Lett. 5;4(7).

Xiao Q, Jackson JJ, Basak A, Bowler JM, Miller BG, Zakarian A. (2013) Enantioselective synthesis of tatanans A-C and reinvestigation of their glucokinase-activating properties. Nat Chem. 5(5):410-6.


Expand All

Joseph Bowler focuses his practice on patent prosecution and counseling for clients in the life sciences and biotechnology industries. He has extensive knowledge in the areas of protein biochemistry, synthetic biology, and next-generation sequencing.

Joseph's doctoral work at Florida State University focused on investigating the mechanism of small-molecule activation of an enzyme implicated in the pathogenesis of diabetes. He also developed an in vivo screening method which integrated a plasmid-based library with a genetic selection system to identify novel therapeutic peptides.

  • Boston Patent Law Association
  • Joseph M. Schor Fellowship in Biochemistry, Florida State University
  • Trustee Academic Scholarship, Suffolk University Law School
  • Jurisprudence Award in Professional Responsibility, Suffolk University Law School

Scientific Publications

Whittington AC, Larion M, Bowler JM, Ramsey KM, Brüschweiler R, Miller BG. (2015) Dual allosteric activation mechanisms in monomeric human glucokinase. Proc Natl Acad Sci USA. 15;112(37):11553-8. 

Bowler JM, Hervert KL, Kearley ML, Miller BG. (2013) Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose. ACS Med Chem Lett. 5;4(7).

Xiao Q, Jackson JJ, Basak A, Bowler JM, Miller BG, Zakarian A. (2013) Enantioselective synthesis of tatanans A-C and reinvestigation of their glucokinase-activating properties. Nat Chem. 5(5):410-6.

Blogs

May 1, 2017

In IPRs, Section 112 Can Play a Critical Role—Even Late in the Game